Previous literature examining the impact of SIRP:CD47 signaling has primarily focused on host immunity in the context of cancer development; hence, little is currently known about how this pathway relates to pancreatic β-cell development and survival in the context of T1D pathogenesis. Here, SIRPA is linked to type 1 diabetes mellitus.